Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyclosporine A in Shockable Out-of-hospital Cardiac Arrest
NCT02887807Phase 3Withdrawn
- Sponsor
- Hospices Civils de Lyon
- Start
- Jan 2017
- Primary completion
- Jan 2019
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cyclosporine in cardiac arrest (SCA), sponsored by Hospices Civils de Lyon. Planned start Jan 2017; status: withdrawn.
02
Drugs
cyclosporine
03
Conditions
cardiac arrest (SCA)
Beyond the preview
Go deeper on NCT02887807.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02887807.